Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational approaches to resistance: using saquinavir

C Boucher1

  • 1Department of Virology, Eykman-Winkler Institute, University Hospital Utrecht, The Netherlands.

AIDS (London, England)
|November 1, 1996
PubMed
Summary

HIV protease inhibitor resistance, particularly to saquinavir, develops slowly and in few patients. Saquinavir offers prolonged activity in combination therapy without limiting future HIV treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A quality improvement project to increase self-administration of medicines in an acute hospital.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2018
Same author

Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa.

Journal of neuroendocrinology·2011
Same author

Histoplasmosis..

Canadian family physician Medecin de famille canadien·2011
Same author

[Modalities for the functionning of a Care Center for women at high risk for breast and ovarian cancers: The French experience of Tenon Hospital].

Gynecologie, obstetrique & fertilite·2010
Same author

Specific genes from the potato brown rot strains of Ralstonia solanacearum and their potential use for strain detection.

Phytopathology·2009
Same author

MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.

Journal of medical genetics·2009

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • HIV protease inhibitors are crucial in managing HIV infection.
  • Understanding drug resistance patterns is essential for effective treatment strategies.

Purpose of the Study:

  • To review HIV protease inhibitor resistance patterns, focusing on saquinavir.
  • To analyze how resistance and cross-resistance influence HIV disease management.

Main Methods:

  • Review of in vitro and in vivo studies on saquinavir resistance.
  • Analysis of mutation patterns (L90M, G48V) associated with saquinavir resistance.
  • Examination of cross-resistance data with other protease inhibitors.

Main Results:

  • Saquinavir resistance is linked to specific mutations (L90M, G48V) distinct from other protease inhibitors.
  • Long-term saquinavir use generally does not induce significant cross-resistance.
  • Over 80% of patients on saquinavir combination therapy responded to other protease inhibitors in preliminary studies.

Conclusions:

  • Saquinavir resistance develops slowly and affects a minority of patients.
  • Saquinavir's resistance profile differs from other HIV protease inhibitors.
  • Saquinavir is a suitable first-line protease inhibitor for combination therapy, preserving subsequent treatment options.

Related Experiment Videos